Description: This session discussion is about employer mandates, state regulations [retirement communities & HMOs, NAIC rate regulation exposure draft ], relations with regulators and relations with health care providers. From Record of the Society of Actuaries Vol. 15, No. 3A.

Description: In this session 2PD of the 2004 Valuation Actuary Symposium panelists share their perspectives on valuation-actuary-related issues, including the hot issues from a regulatory concern.

Description: This session addressed the following regarding benefit plan design to control claim costs: What has been tried? What works? and What else can be tried?

Description: This session discussion is about AIDS for health actuaries, contract limits, underwriting practices, regulations on underwriting, claim reserving, recent experience and future outlook. From Record of the Society of Actuaries Vol. 15, No. 1.

Description: This session is about individual medical and regulatory issues, loss-ratio requirements, form and rate approval, compliance and reporting issues. From Record of Society of Actuaries Vol. 19, No. 4B.

Description: This session discusses the Academy's efforts to address health reform, the latest HIAA activities in the health care debate, and industry implications for proposed legislation. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This session discussion is about state risk pools, Massachusetts programs, federal catastrophic coverage and mandated minimum health benefit coverage. From Record of the Society of Actuaries 1987 Vol. 13, No. 4B.

Description: Many insurers have one or more existing blocks of LTC insurance coverage. As products are revised, older policies are affected greatly. This session discusses possible strategies for dealing with older policies. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 119.

Description: Panelists at this session of the SOA 1998 Maui II Spring Meeting discuss prescription drug issues including the drivers or cost, employer response to increasing costs, and how this issue is addressed in mergers and acquisitions of pharmaceutical companies.

Description: Discussion of various group life and health insurance topics, including: A. Amount of group dental insurance being written and benefit provisions currently being offered and financial experiences of the coverages to date. B. Problems of professional association groups? C. Current level of interest in group paid-up or group permanent.